DEERFIELD, Ill. July 2, 2008 - Siemens Healthcare Diagnostics received CE marking approval to sell the hepatitis B virus e-antigen (HBeAg) and antibody to the hepatitis B virus (anti-HBe) tests in the European marketplace. More

MALVERN, Pa., June 23, 2008 - The Premier healthcare alliance Purchasing Partners division recently announced that Siemens Healthcare Diagnostics (www.siemens.com/diagnostics) was one of 15 winners chosen for the Pinnacle Award out of more than 800 eligible suppliers, representing the top two percent of healthcare equipment suppliers. More

DEERFIELD, IL. May 8, 2008 - Siemens Healthcare and Laboratory Corporation of America® Holdings (LabCorp®) today announced that they have entered a non-exclusive agreement to discuss future possibilities to co-develop new clinical diagnostic tests in the areas of companion diagnostics, metabolic syndrome, oncology and diabetes. More

Donal Quinn has been appointed new head of the Diagnostics division of the Siemens Healthcare Sector. In his new position, Quinn succeeds Jim Reid-Anderson, who on May 1st became the new CEO of this sector. Prior to his new job, Quinn served as Executive Vice President and Chief Customer Officer of the Diagnostics division since November 2007. More

DEERFIELD, IL., Feb. 18, 2008 ― Siemens Healthcare (www.siemens.com/diagnostics) announced today that its VERSANT™ 440 Molecular System has been approved for marketing by the U.S. Food and Drug Administration (FDA) for use with the VERSANT HCV RNA 3.0 assay for management of HCV-infected patients undergoing antiviral therapy. More

Deerfield, IL, January 16, 2008  Siemens Healthcare Diagnostics, today announced that it has launched the LOCI® Folate, LOCI® B12, and LOCI® Ferritin tests for use on the Dimension Vista® 1500 Intelligent Lab System, an ultra-integrated chemistry analyzer More

DEERFIELD, IL, Dec. 20, 2007 – Siemens Medical Solutions Diagnostics today announced the introduction of the MicroScan® WalkAway® plus Systems for mid- and high-volume clinical diagnostic microbiology laboratories. More

Siemens has successfully completed the acquisition of Dade Behring Holdings, Inc. The laboratory diagnostics company joins the existing business of Siemens Medical Solutions Diagnostics. As the market leader in the attractive and rapidly growing field of in vitro diagnostics, Siemens now can offer its customers a unique and comprehensive healthcare solutions' portfolio, which brings together the entire medical imaging, laboratory diagnostics and clinical information technology (IT) value chain under one roof. More

Siemens Medical Solutions Diagnostics, a leader in the in vitro diagnostic industry, announced that they have signed an agreement with B-R-A-H-M-S Aktiengesellschaft for the rights to develop, produce and distribute a Procalcitonin assay used to assist with the early diagnosis of patients at risk for progression to severe sepsis. More

As the cash tender offer expired at 12:00 midnight on Oct. 31, 2007, Siemens intends to accept all validly tendered shares of U.S.-based laboratory diagnostics company Dade Behring. Siemens expects to close the transaction on or about Nov. 6, 2007. More

TARRYTOWN, NY, October 24, 2007 – Siemens Medical Solutions Diagnostics today announced that the TRUGENE®
HIV-1 Genotyping Kit and OpenGene DNA Sequencing System are now supported by the Apple iMac OSX operating system. The TRUGENE iMac OSX-based system provides an integrated computational system that delivers enhanced data management, simplified system configuration and networking support as well as increased flexibility and throughput for laboratories that provide genotype and gene sequence information. The system is available in Europe, Asia-Pacific, Canada, South America and Latin America as a CE marked product. More

TARRYTOWN, NY, October 4, 2007 – Siemens Medical Solutions Diagnostics, announced today that it has been selected by MedAssets Supply Chain Systems, a Group Purchasing Organization (GPO) and supply chain management company, to provide Chemistry, Automation, and Immunoassay solutions for its facilities. More

Tarrytown, N.Y., October 2, 2007 - Siemens Medical Solutions Diagnostics announced today worldwide availability of version 2.0 software for the Rapidlab 1200® Series Blood Gas System. The new software will be a required upgrade for all existing customers and included on all Rapidlab 1200 systems in the future. More

TARRYTOWN, NY, September 25, 2007 – Siemens Medical Solutions Diagnostics today announced the launch of the DCA Vantage™ Analyzer, a point-of-care (POC) diabetes patient management platform providing glycosylated hemoglobin (HbA1c), Microalbumin/Creatinine and Albumin-to-Creatinine tests for diabetes management. The DCA Vantage Analyzer is critical for monitoring a patient’s glycemic control and helps physicians to encourage patient compliance by delivering actionable test results during a patient visit. The system delivers the simplicity and convenience required at the point of care with no sample or reagent preparation steps. The DCA Vantage Analyzer has been launched in Europe. The product is pending FDA clearance and is not yet available for in vitro diagnostic use in the US. More

Tarrytown, N.Y., July 31, 2007 – Siemens Medical Solutions Diagnostics, announced today that it has been selected by Amerinet, one of the nation's leading purchasing organizations in the health care industry, to provide a complete line of immunoassay, chemistry, and automation solutions. The agreement meets the needs of Amerinet’s members by offering a diversified product portfolio, tiered pricing schedule, value-added offering, comprehensive menu and rapid turnaround of quality test results. More

Siemens has signed a merger agreement with US-based Dade Behring, Inc., a leading clinical laboratory diagnostics company. Siemens intends to acquire all outstanding shares of Dade Behring by submitting a cash offer to the Dade Behring shareholders of US$77 per common share. The planned acquisition has a total transaction volume of approximately US$7 billion (roughly €5 billion). 
Other press releases and publicly disseminated information can be found by visiting the online USA Press Room at www.usa.siemens.com/medical-pressroom. - Siemens Medical Solutions USA Public Relations More

Tarrytown, N.Y. July 19, 2007 - Siemens Medical Solutions Diagnostics announced today that it has been awarded an agreement with Novation, the healthcare contracting services company of VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances to provide chemistry, immunochemistry and automation solutions to VHA, UHC and Healthcare Purchasing Partners International (HPPI) members. This agreement signifies the continued growth between Siemens and Novation and is effective July, 2007. More

Tarrytown, N.Y., July 19, 2007 - Siemens Medical Solutions Diagnostics today announced the introduction of the ADVIA Centaur® Cyclosporine (CsA) assay, an easy to use automated test offering laboratories a highly specific immunoassay for the Cyclosporine A parent compound. More

Tarrytown, NY and Southampton, UK, July 18, 2007 - Siemens Medical Solutions Diagnostics today announced the availability of its Enhanced Liver Fibrosis (ELF)™ test, the first CE-marked, standardized non-invasive blood test for assessing the status of liver fibrosis. The Siemens ELF test was first validated in an international multicenter cohort study and is now available through iQur, Ltd., Southampton, UK, as a testing service for patient management. More

San Diego, July 17, 2007 - Siemens Medical Solutions Diagnostics today announced the availability of the ADVIA 1800 chemistry system, the latest addition to their ADVIA chemistry line of advanced chemistry analyzers. The ADVIA 1800 features an intuitive software interface and advanced chemistry testing capabilities to deliver optimized performance and reliable results. More

San Diego, July 16, 2007–Siemens Medical Solutions Diagnostics is showcasing its comprehensive portfolio of performance-driven solutions for the first time at the American Association of Clinical Chemistry (AACC) Conference in San Diego (July 17 – 19, booth #3411)¹. This portfolio is a result of bringing together two strong leaders in the diagnostics industry: former Bayer Healthcare Diagnostics and former DPC. More

Tarrytown, NY, May 16, 2007 – Siemens Medical Solutions Diagnostics announced today that the VERSANT 440 Molecular System has been approved for marketing by Health Canada for viral load testing of the human immunodeficiency virus (HIV) and the hepatitis C virus (HCV). The enhanced automation of the VERSANT 440 provides laboratories with greater throughput and less hands-on time, maximizing productivity to meet the evolving needs of the clinical laboratory. More

TARRYTOWN, NY, April 9, 2007 – Siemens Medical Solutions Diagnostics, www.usa.siemens.com/medical, announced today that it has been selected by Premier Inc., www.premierinc.com, the nation’s largest Group Purchasing Organization (GPO), to provide a complete line of immunoassay, chemistry, automation and urinalysis solutions. The agreement is part of Premier’s recently issued “Core Lab” segment which sought solution providers in six separate bid categories. Siemens has been selected to provide the Integrated and Urinalysis solutions. More

TARRYTOWN, NY, March 26, 2007 – Siemens Medical Solutions Diagnostics www.usa.siemens.com/medical today announced the launch of the Clinitek Advantus urine chemistry analyzer, the newest member of the Clinitek® family of urine analyzers. The Clinitek Advantus™ analyzer enables automated reading of Siemens’ Multistix® family of urinalysis testing strips in medium to high throughput settings. In today’s busy laboratory environment, dependable solutions are critical to providing the level of service that the hospital and/or laboratories demand. Siemens’ laboratory urinalysis portfolio provides options for productivity solutions that help meet those challenges, with high-quality test results. More

HOUSTON, March 25, 2007 ― Siemens Medical Solutions Diagnostics will showcase its broad portfolio of diagnostic solutions for the first time at the annual Clinical Laboratory Managers Association (CLMA) Conference and Exhibition from March 24 -27 in Houston, Texas (booth #821 and RV location at #550). More

Hercules, CA and Tarrytown, NY – January 31, 2007 – Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, and Siemens Medical Solutions Diagnostics, a wholly owned subsidiary of Siemens Medical Solutions USA, Inc., today announced a joint marketing agreement under which Bio-Rad will provide its quality control products and Unity™ QC data management solutions for use on Siemens Diagnostics’ ADVIA® Chemistry and ADVIA Centaur® Immunoassay Systems. The combination of the quality control products and data management solutions will help ensure Siemens Diagnostics customers of the reliability and precision of their clinical laboratory test systems. More

The acquisition of Bayer Healthcare's diagnostic division by Siemens Medical Solutions has been completed. Bayer Diagnostics and Diagnostic Products Corporation (DPC), acquired in July 2006, were merged into a single business unit on January 1, 2007. The new entity, "Siemens Medical Solutions Diagnostics," is a wholly owned subsidiary of Siemens Medical Solutions USA, Inc. and employs more than 8,000 people worldwide. Siemens Medical Solutions Diagnostics, headquartered in Tarrytown, N.Y. and Los Angeles, CA, holds a No. 2 position in the worldwide immunodiagnostics market. More